LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial

OBJECTIVE: As glucagon-like peptide-1 receptor agonists lower blood pressure (BP) in type 2 diabetes mellitus (T2DM), we examined BP control in relation to targets set by international bodies prior to randomization in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrie, John R., Marso, Steven P., Bain, Stephen C., Franek, Edward, Jacob, Stephan, Masmiquel, Luis, Leiter, Lawrence A., Haluzik, Martin, Satman, Ilhan, Omar, Mohamed, Shestakova, Marina, Van Gaal, Luc, Mann, Johannes F., Baeres, Florian M.M., Zinman, Bernard, Poulter, Neil R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
ORIGINAL PAPERS: Diabetes mellitus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856174/
https://www.ncbi.nlm.nih.gov/pubmed/26855018
http://dx.doi.org/10.1097/HJH.0000000000000890

Ejemplares similares

Ejemplares similares